Skip to main content
Annals of Intensive Care
Fig. 3 | Annals of Intensive Care

Fig. 3

From: Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study

Fig. 3

Forest plot analysis for the association between substitutive nebulized colistin dosage and day-14 clinical failure. ICU-admitted patients with nosocomial pneumonia caused by CR-GNB were categorized as high-dose nebulized colistin (> 6 MIU/day CMS) and low-dose nebulized colistin (≤ 6 MIU/day CMS). ICU, intensive care units; CR-GNB, carbapenem-resistant Gram-negative bacteria; CLD, chronic lung disorders (including COPD, asthma, bronchiectasis, and pulmonary fibrosis); VAP, ventilator-associated pneumonia; HAP, hospital-acquired pneumonia; APACHE II, Acute Physiology and Chronic Health Evaluation II; PF, PaO2/FiO2 ratio

Back to article page